Trial Profile
Abatacept is a Suitable Biologic Disease Modifying Anti-Rheumatic Drugs in Patients with Anti-Ss-a Antibodies-Positive Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 02 Sep 2015 New trial record